WOW - SOUNDS GOOD REALLY : "....CAPR Key points: 1. 100% efficient for 6 COVID-19 acute respiratory distress syndrome (ARDS)
2. FDA approved it to treat up 20 additional COVID-19 patients. ( the test may finish in one month)
3. CAP-1002 are very efficient --- effect in one to four days and no adverse effect
4. CAP-1002 have demonstrated favorable modulation of various inflammatory cytokins and regular the immune response. Which is the key to cure the later COVID-19 patients.
5, CAP-1002 has applaied to 150 patients which showed it is a novel mechanism of GAME CHANGE help COVID-19
6, Next event: CAP-1002 for Duchenne muscular dystrophy (DMD) data will be publish in mid-May 2002...."